- Home
- SRDX vs AAM Comparison
SRDX vs AAM Comparison
Compare SRDX & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- AAM
- Stock Information
- Founded
- SRDX 1979
- AAM 2024
- Country
- SRDX United States
- AAM United States
- Employees
- SRDX N/A
- AAM N/A
- Industry
- SRDX Medical/Dental Instruments
- AAM
- Sector
- SRDX Health Care
- AAM
- Exchange
- SRDX Nasdaq
- AAM Nasdaq
- Market Cap
- SRDX 457.0M
- AAM 460.0M
- IPO Year
- SRDX 1998
- AAM 2024
- Fundamental
- Price
- SRDX $32.03
- AAM $10.51
- Analyst Decision
- SRDX Buy
- AAM
- Analyst Count
- SRDX 3
- AAM 0
- Target Price
- SRDX $43.00
- AAM N/A
- AVG Volume (30 Days)
- SRDX 244.1K
- AAM 14.7K
- Earning Date
- SRDX 11-05-2025
- AAM 01-01-0001
- Dividend Yield
- SRDX N/A
- AAM N/A
- EPS Growth
- SRDX N/A
- AAM N/A
- EPS
- SRDX N/A
- AAM 0.32
- Revenue
- SRDX $120,801,000.00
- AAM N/A
- Revenue This Year
- SRDX N/A
- AAM N/A
- Revenue Next Year
- SRDX $3.38
- AAM N/A
- P/E Ratio
- SRDX N/A
- AAM $32.60
- Revenue Growth
- SRDX N/A
- AAM N/A
- 52 Week Low
- SRDX $26.00
- AAM $9.96
- 52 Week High
- SRDX $40.39
- AAM $10.79
- Technical
- Relative Strength Index (RSI)
- SRDX 52.07
- AAM 57.37
- Support Level
- SRDX $31.34
- AAM $10.48
- Resistance Level
- SRDX $33.17
- AAM $10.49
- Average True Range (ATR)
- SRDX 0.70
- AAM 0.01
- MACD
- SRDX -1.98
- AAM 0.00
- Stochastic Oscillator
- SRDX 92.20
- AAM 100.00
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.